|
|
Links to Published Papers
ECHINILIN
is the collective effort of eight years of immunological studies
conducted by scientists at Inovobiologic Inc. in collaboration with researchers at the universities
of Alberta, British Columbia and Dalhousie in Canada, as well
as Heinrich-Heine University in Dusseldorf, Germany, and Karl-Franzens
University in Graz, Austria.
ECHINILIN is the only phytopharmaceutical
extract of any Echinacea species that provides standardized
concentrations of the three immunomodulating bioactives alkylamide,
polysaccharide and cichoric acid.
ECHINILIN
is the only patented phytopharmaceutical that has completed
two randomized, double-blinded and placebo-controlled clinical
trials, which clearly demonstrated its ability to enhance
the innate immune response resulting in a faster recovery
from upper respiratory infections. Clinical studies have proven
that ECHINILIN
reduces the severity of cold and flu symptoms by 23%, on average.
|
"Efficacy
of a standardized Echinacea preparation ECHINILIN for the treatment
of the common cold: randomized, double-blind, placebo-controlled trial"
The Journal of Clinical Pharmacy and Therapeutics
Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TD, Basu TK.
Department of Agricultural, Food and Nutritional Science, University
of Alberta, Edmonton, AB, Canada.
"Alkylamides
of Echinacea purpurea stimulate alveolar macrophage function
in normal rats"
International Immunopharmacology
Goel V, Chang C, Slama JV, Barton
R, Bauer R, Gahler R, Basu TK.
Department of Agricultural, Food and Nutritional Science, University
of Alberta, Edmonton, Canada.
"Echinacea stimulates macrophage function in the lung
and spleen of normal rats"
The Journal of Nutritional Biochemistry
Goel V, Chang C, Slama J, Barton R, Bauer R, Gahler R, Basu T.
Department of Agricultural, Food and Nutritional Science, University
of Alberta, Edmonton, AB, Canada
|
The Gold Standard
in IMMUNE ENHANCEMENT
|
|
Validated
|
Research
|
Results
|
|
|
Identify
the three key active constituents in Echinacea |
• Alkylamide
• Polysaccharide
• Cichoric Acid
|
|
|
Identify
Echinacea species with greatest levels of key actives |
• Echinacea purpurea
|
|
|
Determine
each active’s stimulatory effect on immune system |
• All three actives have stimulatory effect on
immune system
|
|
|
Determine
if immunomodulation is dose dependent |
• Dose dependent
• Optimal dosing levels determined
|
|
|
Phase II
clinical evaluation of effectiveness and safety |
• Biological markers for innate immune system
stimulation high
• Statistically significant reduction in duration
and severity of URI
• No toxicity
|
|
|
Phase
II clinical evaluation of effectiveness and safety |
• Reproducible, statistically significant results
• Biological markers for immune system stimulation
high
• Consistent and significant reduction in duration
and severity of common cold
• No toxicity
• No adverse reactions
|
|
| |
|
